David Fredrickson, Executive Vice-President of Oncology Business at AstraZeneca, shared a post on LinkedIn:
“What would be the soundtrack to your ambition?
Ahead of this year’s ASCO, Susan Galbraith and I chose the top songs that embody our Oncology ambition and talked about which innovations will have the greatest impact on patients.
The science is moving fast, but the question that stays with me is how do we turn that momentum we see here at ASCO into progress for patients with cancer as quickly as possible.”
Proceed to the video attached to the post.
Other articles featuring David Fredrickson on OncoDaily.